26-valent pneumococcal conjugate vaccine (Beijing Luzhu Biopharmaceutical)

26价肺炎球菌结合疫苗 （北京智飞绿竹生物制药）

Report date: 2024/08/22 20:00:11

Base Information

Drug Name26-valent pneumococcal conjugate vaccine (Beijing Luzhu Biopharmaceutical)
Drug Alias NameN/A
ClassificationVaccines > Biological material > Bacterial vaccineVaccines > Vaccine type > Multivalent vaccineVaccines > Application > Prophylactic vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPneumococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesBeijing Zhifei Lvzhu Biopharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Zhifei Lvzhu Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsPneumococcal Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A